# Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy

> **NCT07046832** · NA · ENROLLING_BY_INVITATION · sponsor: **MediView XR, Inc.** · enrollment: 104 (estimated)

## Conditions studied

- Oncology
- Interventional Radiology
- Liver Carcinoma
- Renal Carcinoma
- Biopsy

## Interventions

- **DEVICE:** Augmented Reality Guided Biopsy
- **DEVICE:** Ultrasound Guided Biopsy

## Key facts

- **NCT ID:** NCT07046832
- **Lead sponsor:** MediView XR, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-06-27
- **Primary completion:** 2027-06
- **Final completion:** 2027-07
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2025-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07046832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07046832, "Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07046832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*